Citigroup Maintains Neutral on Qiagen, Lowers Price Target to $38
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
Citigroup analyst Patrick Donnelly maintains Qiagen (NYSE:QGEN) with a Neutral and lowers the price target from $55 to $38.
Citigroup analyst Patrick Donnelly maintains Qiagen (NYSE:QGEN) with a Neutral and lowers the price target from $55 to $38.